Viewing posts from December, 2019
Teprotumumab Update
Posted 1 month, 2 weeks agoOn Friday, Dec. 13th, the FDA's Dermatologic and Ophthalmic Drugs Advisory Committee met in Silver Spring, MD to discuss teprotumumab, a potential treatment for active thyroid eye disease.
Page 1 of 1:
- 1
